Novartis India Ltd

Novartis India Summary Chart Analysis Peers Quarters Profit & Loss Balance Sheet Cash Flow Ratios Investors Documents

Novartis India Ltd

₹ 1,365 1.39%
22 May - close price
novartis.in BSE: 500672 NSE: NOVARTIND
About

Novartis India Ltd is primarily engaged in the Business of Wholesale of pharmaceuticals and medical goods.
[1] It imports various medicines to India from different sources across the globe.[2]

Key Points

Business
The company is primarily engaged in the pharmaceutical business in the area of pain management, organ transplantation, neuroscience, etc. [1]

Website BSE NSE
  • Market Cap ₹ 3,371 Cr.
  • Current Price ₹ 1,365
  • High / Low ₹ 1,407 / 750
  • Stock P/E 36.2
  • Book Value ₹ 331
  • Dividend Yield 1.83 %
  • ROCE 16.2 %
  • ROE 11.6 %
  • Face Value ₹ 5.00
Edit ratios

Pros

  • Company has reduced debt.
  • Company is almost debt free.

Cons

  • The company has delivered a poor sales growth of -1.46% over past five years.
  • Company has a low return on equity of 11.9% over last 3 years.
  • Earnings include an other income of Rs.38.8 Cr.

* The pros and cons are machine generated. Pros / cons are based on a checklist to highlight important points. Please exercise caution and do your own analysis.

Peer comparison

Healthcare Healthcare Pharmaceuticals & Biotechnology Pharmaceuticals

Part of BSE Healthcare BSE 1000

Edit Columns
Loading peers table ...

Quarterly Results

Figures in Rs. Crores

Mar 2023 Jun 2023 Sep 2023 Dec 2023 Mar 2024 Jun 2024 Sep 2024 Dec 2024 Mar 2025 Jun 2025 Sep 2025 Dec 2025 Mar 2026
76 91 79 85 81 92 87 93 84 88 90 86 91
67 73 62 65 70 68 69 67 60 60 66 64 70
Operating Profit 9 17 17 20 11 24 18 26 24 27 24 22 21
OPM % 12% 19% 21% 23% 14% 26% 21% 28% 29% 31% 26% 26% 23%
16 12 17 22 10 10 10 11 11 11 9 9 10
Interest 0 0 1 0 0 0 0 0 0 0 0 1 0
Depreciation 2 2 1 0 0 1 1 1 1 1 1 0 0
Profit before tax 23 28 32 41 21 34 28 35 34 37 33 30 30
Tax % -7% 27% 27% 36% 31% 24% 26% 28% 14% 26% 26% 46% 16%
25 20 24 27 15 26 20 25 29 28 24 16 25
EPS in Rs 10.13 8.21 9.59 10.76 5.95 10.42 8.27 10.31 11.87 11.19 9.81 6.52 10.23
Raw PDF

Profit & Loss

Figures in Rs. Crores

Mar 2015 Mar 2016 Mar 2017 Mar 2018 Mar 2019 Mar 2020 Mar 2021 Mar 2022 Mar 2023 Mar 2024 Mar 2025 Mar 2026
870 690 656 564 491 438 381 400 379 335 356 354
874 656 631 570 478 426 355 373 314 270 265 260
Operating Profit -4 34 25 -6 12 12 27 27 65 65 91 94
OPM % -0% 5% 4% -1% 2% 3% 7% 7% 17% 19% 26% 27%
101 207 71 172 78 36 33 -17 58 62 42 39
Interest 0 0 1 6 2 6 8 5 2 1 1 1
Depreciation 4 3 4 3 3 13 12 10 6 3 2 2
Profit before tax 93 237 92 158 86 29 40 -4 115 123 130 130
Tax % 15% 16% 38% 50% 40% 65% 48% -3% 10% 31% 23% 28%
79 198 57 78 52 10 21 -4 103 85 101 93
EPS in Rs 24.75 62.04 20.33 31.74 20.97 4.08 8.46 -1.51 41.86 34.50 40.87 37.74
Dividend Payout % 40% 16% 49% 32% 48% 245% 118% -663% 113% 72% 61% 0%
Compounded Sales Growth
10 Years: -6%
5 Years: -1%
3 Years: -2%
TTM: -1%
Compounded Profit Growth
10 Years: -7%
5 Years: 35%
3 Years: -3%
TTM: -8%
Stock Price CAGR
10 Years: 5%
5 Years: 17%
3 Years: 24%
1 Year: 43%
Return on Equity
10 Years: 8%
5 Years: 11%
3 Years: 12%
Last Year: 12%

Balance Sheet

Figures in Rs. Crores

Mar 2015 Mar 2016 Mar 2017 Mar 2018 Mar 2019 Mar 2020 Mar 2021 Mar 2022 Mar 2023 Mar 2024 Mar 2025 Mar 2026
Equity Capital 16 16 14 12 12 12 12 12 12 12 12 12
Reserves 986 1,178 906 721 747 708 699 679 763 732 773 805
0 0 0 0 0 68 62 24 22 7 5 3
244 239 230 377 223 289 229 242 186 173 158 157
Total Liabilities 1,246 1,433 1,150 1,111 982 1,078 1,002 958 983 925 948 978
8 6 6 5 15 76 64 24 19 7 5 3
CWIP 0 0 0 0 0 0 0 0 0 0 0 0
Investments 0 0 0 0 0 0 0 0 0 0 0 0
1,238 1,426 1,144 1,106 967 1,001 938 934 964 918 943 975
Total Assets 1,246 1,433 1,150 1,111 982 1,078 1,002 958 983 925 948 978

Cash Flows

Figures in Rs. Crores

Mar 2015 Mar 2016 Mar 2017 Mar 2018 Mar 2019 Mar 2020 Mar 2021 Mar 2022 Mar 2023 Mar 2024 Mar 2025 Mar 2026
-60 57 -41 161 -194 -23 -69 39 45 113 75 47
719 -630 424 69 274 56 95 87 -153 33 -3 18
-38 -39 -332 -268 -30 -41 -37 -36 -30 -121 -64 -64
Net Cash Flow 622 -612 51 -38 50 -9 -11 90 -139 26 7 0
Free Cash Flow -64 54 -44 160 -208 -24 -69 38 45 113 75 46
CFO/OP 601% 398% 13% -3,503% -1,210% 124% -127% 210% 65% 115% 99% 87%

Ratios

Figures in Rs. Crores

Mar 2015 Mar 2016 Mar 2017 Mar 2018 Mar 2019 Mar 2020 Mar 2021 Mar 2022 Mar 2023 Mar 2024 Mar 2025 Mar 2026
Debtor Days 35 27 23 28 34 31 37 41 35 45 41 38
Inventory Days 103 92 104 84 111 117 119 117 99 82 74 98
Days Payable 98 89 87 158 168 145 137 148 108 112 93 101
Cash Conversion Cycle 40 30 40 -45 -23 3 19 10 26 15 22 36
Working Capital Days 6 -35 -14 -99 7 -1 62 -23 -37 -59 -45 -46
ROCE % 9% 22% 9% 17% 12% 5% 6% 6% 15% 16% 17% 16%

Insights

In beta
Mar 2015 Mar 2016 Mar 2017 Mar 2018 Mar 2019 Mar 2020 Mar 2021 Mar 2022 Mar 2023 Mar 2024 Mar 2025
Number of Permanent Employees
Count

Log in to view insights

Please log in to see hidden values.

Login
Number of Core Strategic Brands
Brands
Rural Reach - Villages Covered (Arogya Parivar)
Villages
Reach - Healthcare Professionals / Doctors
Count
Distribution Network - Number of Distributors/Dealers
Count
Market Share - Transplant Induction Patients
Percentage

Extracted by Screener AI

Shareholding Pattern

Numbers in percentages

Jun 2023Sep 2023Dec 2023Mar 2024Jun 2024Sep 2024Dec 2024Mar 2025Jun 2025Sep 2025Dec 2025Mar 2026
70.68% 70.68% 70.68% 70.68% 70.68% 70.68% 70.68% 70.68% 70.68% 70.68% 70.68% 70.68%
0.23% 0.32% 0.19% 0.19% 0.19% 0.19% 0.19% 0.19% 0.19% 0.19% 0.19% 0.17%
0.75% 0.52% 0.52% 0.52% 0.52% 0.52% 0.53% 0.53% 0.53% 0.53% 0.63% 0.53%
28.34% 28.47% 28.60% 28.61% 28.60% 28.61% 28.60% 28.61% 28.60% 28.61% 28.50% 28.60%
No. of Shareholders 43,34343,99243,12841,23939,26539,59638,92639,13339,04039,35339,46838,116

* The classifications might have changed from Sep'2022 onwards. The new XBRL format added more details from Sep'22 onwards.

Classifications such as banks and foreign portfolio investors were not available earlier. The sudden changes in FII or DII can be because of these changes.

Click on the line-items to see the names of individual entities.

Documents

Announcements

Annual reports